Bank of New York Mellon Corp Buys 10,654 Shares of International ...
π Bank of New York Mellon Corp increased its IFF position by 0.7% in Q1, adding 10,654 shares to a total holding valued at $115.98 million.
π¦ State Street Corp grew its stake by 1.1% in Q4, now owning over 11 million shares worth $751.87 million.
π First Eagle Investment Management LLC significantly boosted its holdings by 27.5% in Q4, acquiring nearly 1.9 million additional shares.
π° IFF reported Q1 earnings of $1.25 per share, beating analyst estimates of $1.08 and topping revenue expectations at $2.74 billion.
π Revenue declined 3.6% year-over-year to $2.74 billion, though the company maintained a 7.65% return on equity and 7.78% net margin.
π΅ The company declared a quarterly dividend of $0.40 per share, resulting in an annualized yield of 2.1% with a payout ratio of 48.93%.
π UBS Group raised its price target from $75.00 to $86.00 following a research report on May 7th.
π Citigroup lowered its price target to $88.00 but maintained a 'buy' rating in a June 24th report.
π JPMorgan Chase increased its price target from $90.00 to $92.00 and assigned an 'overweight' rating.
π Director Paul J. Fribourg purchased 260,000 shares in June for $19.3 million, increasing his direct ownership by 10.73%.
π MarketBeat reports an average analyst price target of $91.16 based on thirteen buy ratings and five hold ratings.
π IFF operates a global R&D network across North America, Europe, Asia-Pacific, and Latin America focusing on aroma chemistry and biotechnology.
- IFF beat earnings estimates with $1.25 per share versus the consensus of $1.08, demonstrating strong operational performance.
- Revenue of $2.74 billion exceeded analyst expectations of $2.64 billion, indicating robust demand for the company's products.
- Multiple major institutional investors, including State Street and First Eagle, increased their stakes significantly in Q4.
- UBS Group raised its price target to $86.00, reflecting a positive outlook on the stock's valuation potential.
- JPMorgan Chase upgraded its rating to 'overweight' and raised its price target to $92.00, signaling strong institutional confidence.
- The company maintains a healthy dividend yield of 2.1% with a sustainable payout ratio of 48.93%.
- Director Paul J. Fribourg's substantial purchase of 260,000 shares for $19.3 million indicates insider confidence in the business.
- Revenue declined 3.6% year-over-year to $2.74 billion, suggesting potential headwinds in specific end markets or pricing pressures.
- Citigroup lowered its price target from $96.00 to $88.00, indicating some analysts see limited upside at current levels.